Journals Library


HTA - 11/83/01

Pegloticase for the treatment of hyperuricaemia in people with symptomatic gout whose disease is refractory to conventional urate-lowering therapy, or in whom conventional urate-lowering therapy is contraindicated or not tolerated [ID521]

Project title: Pegloticase for the treatment of hyperuricaemia in people with symptomatic gout whose disease is refractory to conventional urate-lowering therapy, or in whom conventional urate-lowering therapy is contraindicated or not tolerated [ID521]

Call to action: 14/79 Batch 21

Research type: Evidence Synthesis

Chief investigator: Professor Eva KaltenthalerORCID logoorcid.org/0000-0002-6185-8321

Contractor: The University of Sheffield

Cost: £65,625.00

Co-investigators: Ms Andrea Shippam, Ms Gillian Rooney.

Started: August 2012 | Status: Project complete

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.

Background & Research Questions

Why the research is being done and what is being asked

Methods

How the research is being done

Publications & Outputs

What the research produced

Outcomes & Impact

What happened as a result of the research

If you would like to receive a notification when this project is updated, please submit your email address below. This will also notify you when the Journals Library report is published.